Endpoints News, the leading source for biopharma news, announced Monday the hiring of three new staffers: Jaimy Lee as deputy editor of newsletters, Andrew Dunn as biopharma correspondent and Ryan Cross as senior science correspondent.
“We’re thrilled to have Ryan, Andrew and Jaimy join the Endpoints News team at this time of rapid growth. In the last few months, the Endpoints team has done
challenging in-depth reporting, great feature stories, and phenomenal breaking news on the industry,” said executive editor Drew Armstrong in a statement. “We plan to announce additional new hires in the coming months, including growing our breaking news and in-depth reporting in Washington.”
Lee has more than 15 years of experience covering health care and business. She was most recently the health editor at MarketWatch, where her work during the Covid-19 pandemic was recognized by SABEW and the Newswomen’s Club of New York.
She has held a mix of editing and reporting roles, including on LinkedIn’s editorial team, where she developed #TheCheckup newsletter and video series.
Dunn was most recently a senior health care reporter at Business Insider focused on the biotech and pharmaceutical industries. He is focused on uncovering and explaining the future of the drug industry, ranging from nascent startups to pharma giants.
Dunn previously worked as a reporter at BioPharma Dive, and his reporting has been cited by news outlets including the Washington Post, CNN, and the New York Times, and he’s appeared on CNBC, C-SPAN, and MSNBC to discuss his work.
Cross joins Endpoints from the Boston Globe, where he covered biotechnology and science. Prior to the Globe, at Chemical & Engineering News he led coverage of Covid-19 vaccines, gene editing, and all things RNA.
His work has appeared in MIT Technology Review, Science, Scientific American, and STAT. He is a graduate of Boston University’s master’s program in science journalism, and he studied genetics, neuroscience, and medicinal chemistry at Purdue University.
Lee, Dunn and Cross will join the newsroom in April.
